img

Global Gastrointestinal Stromal Tumor Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Gastrointestinal Stromal Tumor Market Insights, Forecast to 2034

Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
Market Analysis and InsightsGlobal Gastrointestinal Stromal Tumor Market
Global Gastrointestinal Stromal Tumor market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Gastrointestinal Stromal Tumor industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.
Report Covers
This report presents an overview of global Gastrointestinal Stromal Tumor market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Gastrointestinal Stromal Tumor market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
​​Sun Pharmaceutical
Pfizer
Bayer Aktiengesellschaft
NATCO Pharma
Segment by Type
Stomach
Small Intestine
Others

Segment by Application


Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gastrointestinal Stromal Tumor introduction, etc. Gastrointestinal Stromal Tumor Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Gastrointestinal Stromal Tumor
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Stomach
1.2.3 Small Intestine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialized Cancer Treatment Centers
1.3.5 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2018-2033)
2.2 Global Gastrointestinal Stromal Tumor Growth Trends by Region
2.2.1 Gastrointestinal Stromal Tumor Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastrointestinal Stromal Tumor Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2024-2033)
2.3 Gastrointestinal Stromal Tumor Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gastrointestinal Stromal Tumor by Players
3.1.1 Global Gastrointestinal Stromal Tumor Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gastrointestinal Stromal Tumor, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2022
3.5 Global Key Players of Gastrointestinal Stromal Tumor Head office and Area Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor, Product and Application
3.7 Global Key Players of Gastrointestinal Stromal Tumor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2024-2033)
5 Gastrointestinal Stromal Tumor Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2018-2033)
6.2 North America Gastrointestinal Stromal Tumor Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumor Market Size by Type (2018-2023)
6.2.2 North America Gastrointestinal Stromal Tumor Market Size by Type (2024-2033)
6.2.3 North America Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
6.3 North America Gastrointestinal Stromal Tumor Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumor Market Size by Application (2018-2023)
6.3.2 North America Gastrointestinal Stromal Tumor Market Size by Application (2024-2033)
6.3.3 North America Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
6.4 North America Gastrointestinal Stromal Tumor Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumor Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
6.4.3 North America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2018-2033)
7.2 Europe Gastrointestinal Stromal Tumor Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumor Market Size by Type (2018-2023)
7.2.2 Europe Gastrointestinal Stromal Tumor Market Size by Type (2024-2033)
7.2.3 Europe Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumor Market Size by Application (2018-2023)
7.3.2 Europe Gastrointestinal Stromal Tumor Market Size by Application (2024-2033)
7.3.3 Europe Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
7.4 Europe Gastrointestinal Stromal Tumor Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumor Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
7.4.3 Europe Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gastrointestinal Stromal Tumor Market Size (2018-2033)
8.2 China Gastrointestinal Stromal Tumor Market Size by Type
8.2.1 China Gastrointestinal Stromal Tumor Market Size by Type (2018-2023)
8.2.2 China Gastrointestinal Stromal Tumor Market Size by Type (2024-2033)
8.2.3 China Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
8.3 China Gastrointestinal Stromal Tumor Market Size by Application
8.3.1 China Gastrointestinal Stromal Tumor Market Size by Application (2018-2023)
8.3.2 China Gastrointestinal Stromal Tumor Market Size by Application (2024-2033)
8.3.3 China Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Gastrointestinal Stromal Tumor Market Size (2018-2033)
9.2 Asia Gastrointestinal Stromal Tumor Market Size by Type
9.2.1 Asia Gastrointestinal Stromal Tumor Market Size by Type (2018-2023)
9.2.2 Asia Gastrointestinal Stromal Tumor Market Size by Type (2024-2033)
9.2.3 Asia Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
9.3 Asia Gastrointestinal Stromal Tumor Market Size by Application
9.3.1 Asia Gastrointestinal Stromal Tumor Market Size by Application (2018-2023)
9.3.2 Asia Gastrointestinal Stromal Tumor Market Size by Application (2024-2033)
9.3.3 Asia Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
9.4 Asia Gastrointestinal Stromal Tumor Market Size by Region
9.4.1 Asia Gastrointestinal Stromal Tumor Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Gastrointestinal Stromal Tumor Market Size by Region (2018-2023)
9.4.3 Asia Gastrointestinal Stromal Tumor Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.1.5 Novartis Recent Developments
11.2 ​​Sun Pharmaceutical
11.2.1 ​​Sun Pharmaceutical Company Details
11.2.2 ​​Sun Pharmaceutical Business Overview
11.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
11.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.2.5 ​​Sun Pharmaceutical Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Details
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.4.5 Bayer Aktiengesellschaft Recent Developments
11.5 NATCO Pharma
11.5.1 NATCO Pharma Company Details
11.5.2 NATCO Pharma Business Overview
11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2018-2023)
11.5.5 NATCO Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Stomach
Table 3. Key Players of Small Intestine
Table 4. Key Players of Others
Table 5. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Gastrointestinal Stromal Tumor Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gastrointestinal Stromal Tumor Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gastrointestinal Stromal Tumor Market Share by Region (2018-2023)
Table 9. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gastrointestinal Stromal Tumor Market Share by Region (2024-2033)
Table 11. Gastrointestinal Stromal Tumor Market Trends
Table 12. Gastrointestinal Stromal Tumor Market Drivers
Table 13. Gastrointestinal Stromal Tumor Market Challenges
Table 14. Gastrointestinal Stromal Tumor Market Restraints
Table 15. Global Gastrointestinal Stromal Tumor Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gastrointestinal Stromal Tumor Revenue Share by Players (2018-2023)
Table 17. Global Top Gastrointestinal Stromal Tumor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2022)
Table 18. Global Gastrointestinal Stromal Tumor Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Gastrointestinal Stromal Tumor, Headquarters and Area Served
Table 21. Global Key Players of Gastrointestinal Stromal Tumor, Product and Application
Table 22. Global Key Players of Gastrointestinal Stromal Tumor, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2018-2023)
Table 26. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2024-2033)
Table 28. Global Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gastrointestinal Stromal Tumor Revenue Share by Application (2018-2023)
Table 30. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gastrointestinal Stromal Tumor Revenue Share by Application (2024-2033)
Table 32. North America Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Gastrointestinal Stromal Tumor Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Gastrointestinal Stromal Tumor Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Gastrointestinal Stromal Tumor Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Gastrointestinal Stromal Tumor Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Gastrointestinal Stromal Tumor Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Gastrointestinal Stromal Tumor Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Gastrointestinal Stromal Tumor Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Gastrointestinal Stromal Tumor Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Gastrointestinal Stromal Tumor Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Gastrointestinal Stromal Tumor Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Gastrointestinal Stromal Tumor Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Gastrointestinal Stromal Tumor Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size by Country (2024-2033) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Gastrointestinal Stromal Tumor Product
Table 67. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 68. Novartis Recent Developments
Table 69. ​​Sun Pharmaceutical Company Details
Table 70. ​​Sun Pharmaceutical Business Overview
Table 71. ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Product
Table 72. ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 73. ​​Sun Pharmaceutical Recent Developments
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Gastrointestinal Stromal Tumor Product
Table 77. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 78. Pfizer Recent Developments
Table 79. Bayer Aktiengesellschaft Company Details
Table 80. Bayer Aktiengesellschaft Business Overview
Table 81. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product
Table 82. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 83. Bayer Aktiengesellschaft Recent Developments
Table 84. NATCO Pharma Company Details
Table 85. NATCO Pharma Business Overview
Table 86. NATCO Pharma Gastrointestinal Stromal Tumor Product
Table 87. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2018-2023) & (US$ Million)
Table 88. NATCO Pharma Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Gastrointestinal Stromal Tumor Market Share by Type: 2022 VS 2033
Figure 3. Stomach Features
Figure 4. Small Intestine Features
Figure 5. Others Features
Figure 6. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Gastrointestinal Stromal Tumor Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Specialized Cancer Treatment Centers Case Studies
Figure 11. Other End Users Case Studies
Figure 12. Gastrointestinal Stromal Tumor Report Years Considered
Figure 13. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Gastrointestinal Stromal Tumor Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Gastrointestinal Stromal Tumor Market Share by Region: 2022 VS 2033
Figure 16. Global Gastrointestinal Stromal Tumor Market Share by Players in 2022
Figure 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2022
Figure 19. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
Figure 21. North America Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
Figure 22. North America Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 23. United States Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Gastrointestinal Stromal Tumor Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
Figure 27. Europe Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
Figure 28. Europe Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 29. Germany Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Gastrointestinal Stromal Tumor Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
Figure 37. China Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
Figure 38. Asia Gastrointestinal Stromal Tumor Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
Figure 40. Asia Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
Figure 41. Asia Gastrointestinal Stromal Tumor Market Share by Region (2018-2033)
Figure 42. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Gastrointestinal Stromal Tumor Market Share by Country (2018-2033)
Figure 52. Brazil Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Gastrointestinal Stromal Tumor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 59. ​​Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 61. Bayer Aktiengesellschaft Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 62. NATCO Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed